Antibiotic Guidelines

Chapter 12: Gastrointestinal Tract Infections

Antibiotic Guidelines
Chapter 12: Gastrointestinal Tract Infections
Read Document

Helicobacter pylori

Diagnosis

  • Non-invasive: stool antigen, H. pylori IgG, urease breath test
  • Invasive (biopsy): histology, culture, PCR

Treatment Recommendations:

  • Treat all H. pylori positive patients
  • Confirm eradication ≥4 weeks after treatment
  • Base regimen on resistance patterns and exposure history

Triple Therapy (Initial Regimen – No Clarithromycin Exposure)

                 
DrugFrequency
Proton Pump Inhibitor (PPI)PO 12-hourly
Amoxicillin 1g OR Metronidazole 400 mgPO 12-hourly
Clarithromycin 500 mgPO 12-hourly

Treat for 14 days

Non-Bismuth Quadruple Therapy (Alternative Initial Regimen)

Same as above, but include both Amoxicillin AND Metronidazole AND Clarithromycin

Bismuth Quadruple Therapy (2nd-line or alternative for allergy)

  • PPI + Bismuth 240 mg + Tetracycline OR Doxycycline + Metronidazole
  • PO 12-hourly, 14 days

Fluoroquinolone Triple Therapy (for failed regimens)

  • PPI + Amoxicillin or Metronidazole + Levofloxacin 500 mg PO 12-hourly × 14 days

C. difficile Infection (CDI)

Key Points:

  • Caused by broad-spectrum antibiotics
  • Treat only symptomatic patients
  • Always stop inciting antibiotic

Mild to Moderate Disease:

         
DrugAdultsChildren
Metronidazole400 mg PO 8-hourly7.5 mg/kg PO 8-hourly

Treat 10–14 days

Severe Disease:

  • Vancomycin 125 mg PO 6-hourly (adults)
  • 40 mg/kg/day PO ÷ q6h (children)
  • Increase to 500 mg PO q6h if no improvement

Fulminant or Critically Ill:

  • Vancomycin 500 mg PO q6h
  • PLUS Metronidazole 500 mg IV q6h

Salvage Therapy:

  • Tigecycline 100 mg IV load, then 50 mg IV 12-hourly × 10–14 days

Treatment Failures:

  • Repeat vancomycin or tapering doses
  • Faecal transplant or fidaxomicin for recurrence (if available)

Salmonella

NTS – Intestinal (usually self-limiting)

Antibiotics for high-risk patients only:

             
DrugAdultChild
Ciprofloxacin400 mg PO 12-hourly20–30 mg/kg/day PO ÷ q12h
Azithromycin500 mg PO daily5–12 mg/kg PO daily

Duration: 7–14 days

NTS – Extra-intestinal:

  • Ceftriaxone, Cefotaxime, or Levofloxacin IV × 14 days

Typhoid Fever

  • Ciprofloxacin or Levofloxacin OR Ceftriaxone (avoid quinolones if acquired in Asia)
  • Add dexamethasone for severe disease

Shigella (Shigellosis)

  • Empiric oral therapy: Ciprofloxacin or Azithromycin
  • IV therapy: Ceftriaxone 1–2 g daily (adults), 50 mg/kg (children)
  • Duration: 3–10 days depending on severity

Campylobacter

  • Self-limiting; treat if severe, prolonged, or in immunocompromised

             
DrugDuration
Azithromycin 500 mg PO daily3–14 days
Ciprofloxacin or Levofloxacin3–14 days

E. coli Diarrhoea

  • ETEC: treat travellers' diarrhoea (Ciprofloxacin or Azithromycin × 3 days)
  • EHEC: avoid antibiotics (↑HUS risk)
  • EAEC: Ciprofloxacin × 3 days
  • EIEC: treat as Shigella

Cholera

  • Doxycycline 300 mg PO once OR
  • Azithromycin 1 g PO once
  • Rehydration is key

Yersinia

  • Only treat severe/systemic cases

             
TherapyDrug(s)
OralCiprofloxacin or Cotrimoxazole
IVCeftriaxone + Gentamicin

Viral Gastroenteritis

  • Self-limiting; no antibiotics
  • Supportive care: fluids, antiemetics (adults), probiotics
  • Avoid anti-motility in children

Amoebiasis (E. histolytica)

Mild to Moderate:

  • Metronidazole OR Tinidazole × 7–10 days
  • Follow with luminal agents to clear cysts (Paromomycin or Diloxanide)

Giardiasis

  • Metronidazole OR Tinidazole OR Albendazole
  • Recurrent cases: consider longer course or switch class

Cryptosporidiosis

  • Self-limiting in healthy hosts
  • Treat immunocompromised with:
    • ART (for HIV), plus supportive care
    • ± Nitazoxanide, Paromomycin, Azithromycin

Blastocystis hominis

  • Often incidental; treat only if symptomatic and no other pathogen found
  • Metronidazole or Cotrimoxazole

Intra-Abdominal Infections (IAI)

Community-acquired:

  • Low-risk: Amox-clav, Ertapenem, or Ceftriaxone + Metronidazole
  • High-risk: Meropenem or Pip-tazo OR Cefepime + Metronidazole

Healthcare-associated:

  • Empiric therapy: Meropenem, Imipenem, Pip-tazo
  • Add Vancomycin for MRSA
  • Add antifungal if Candida is isolated